BEGIN:VCALENDAR VERSION:2.0 PRODID:-//CURE GABA-A - ECPv6.15.20//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-ORIGINAL-URL:https://curegabaa.org X-WR-CALDESC:Events for CURE GABA-A REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/Los_Angeles BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20230312T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20231105T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20240310T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20241103T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20250309T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20251102T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20260308T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20261101T090000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20230312T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20231105T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20240310T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20241103T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20250309T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20251102T060000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:Asia/Krasnoyarsk BEGIN:STANDARD TZOFFSETFROM:+0700 TZOFFSETTO:+0700 TZNAME:+07 DTSTART:20250101T000000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240213T130000 DTEND;TZID=America/Los_Angeles:20240213T140000 DTSTAMP:20260420T020848 CREATED:20240210T183001Z LAST-MODIFIED:20240213T020148Z UID:2403-1707829200-1707832800@curegabaa.org SUMMARY:Cure GABA-A | What is Project FIND-OUT with Elizabeth Rountree DESCRIPTION:The overall goal of Project FIND-OUT is to facilitate early and accurate genetic diagnosis of rare genetic neurodevelopmental disorders\n\n\nFor Families Project FIND-OUT \n \nThe overall goal of Project FIND-OUT is to facilitate early and accurate genetic diagnosis of rare genetic neurodevelopmental disorders in infants between the ages of 3-12 months in the United States. \nFamilies who participate will receive the following free services: \n\nMeet with a genetic counselor\nReport with your child’s genetic testing results\nConnect with a specialist\, who can help you understand next steps and potential treatment options\nParticipate in research\n\nBy participating in Project FIND-OUT\, you will contribute to an important research study on the value of genetic testing. We hope this study will lead to the development of guidelines for physicians and health insurance companies. Having guidelines may make it easier for other families to get genetic testing in the future and a genetic diagnosis in the future. Lastly\, getting children diagnosed earlier will speed up access to new treatment options URL:https://curegabaa.org/event/cure-gaba-a-what-is-project-find-out-with-elizabeth-rountree/ ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/02/d1adc8e3e09df41f8bec0203f8dae9bc.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240213T130000 DTEND;TZID=America/Los_Angeles:20240213T140000 DTSTAMP:20260420T020848 CREATED:20240210T183002Z LAST-MODIFIED:20240210T183002Z UID:2404-1707829200-1707832800@curegabaa.org SUMMARY:Cure GABA-A | What is Project FIND-OUT with Elizabeth Rountree DESCRIPTION:The overall goal of Project FIND-OUT is to facilitate early and accurate genetic diagnosis of rare genetic neurodevelopmental disorders\n\n\nFor Families Project FIND-OUT \n \nThe overall goal of Project FIND-OUT is to facilitate early and accurate genetic diagnosis of rare genetic neurodevelopmental disorders in infants between the ages of 3-12 months in the United States. \nFamilies who participate will receive the following free services: \n\nMeet with a genetic counselor\nReport with your child’s genetic testing results\nConnect with a specialist\, who can help you understand next steps and potential treatment options\nParticipate in research\n\nBy participating in Project FIND-OUT\, you will contribute to an important research study on the value of genetic testing. We hope this study will lead to the development of guidelines for physicians and health insurance companies. Having guidelines may make it easier for other families to get genetic testing in the future and a genetic diagnosis in the future. Lastly\, getting children diagnosed earlier will speed up access to new treatment options URL:https://curegabaa.org/event/cure-gaba-a-what-is-project-find-out-with-elizabeth-rountree-2/ ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/02/d1adc8e3e09df41f8bec0203f8dae9bc-1.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240215T084500 DTEND;TZID=America/Los_Angeles:20240215T094500 DTSTAMP:20260420T020848 CREATED:20240127T054445Z LAST-MODIFIED:20240214T204442Z UID:2084-1707986700-1707990300@curegabaa.org SUMMARY:Cure GABA-A | Recommended Physician Meet and Greet | Dr. Pamela Pojomovsky DESCRIPTION:Dr. Pamela Pojomovsky McDonnell\, MD\, pediatric neurologist\, Cure GABA-A’s Recommended Physicians at Children’s Hospital of Philadelphia.\n\n\nJoin us for an educational session with Dr. Pamela Pojomovsky McDonnell\, MD\, pediatric neurologist\, Cure GABA-A’s Recommended Physicians at Children’s Hospital of Philadelphia. \nPamela Pojomovsky McDonnell\, MD\, is a pediatric neurologist in the Division of Neurology at Children’s Hospital of Philadelphia (CHOP). She specializes in helping children with epilepsy. Dr. McDonnell had a personal reason for choosing her specialty. \n“My sister had epilepsy when she was a child\, which made me want to help children and families with neurologic conditions\,” she says. “I later developed an interest in science and particularly in how the brain works.” She notes that although epilepsy affects just 1% of the population\, it’s morbidity is quite high. Fortunately\, many tools are available to help control the disorder. A native of Argentina\, Dr. McDonnell enjoys working with Spanish speakers who may otherwise have trouble accessing appropriate care due to language barriers. Along with her clinical work\, she is an Assistant Professor of Neurology at the Perelman School of Medicine at the University of Pennsylvania. \nDr. McDonnell is enthusiastic about new developments in genetics that may one day allow doctors to predict the course of epilepsy and target treatments accordingly. She is a member of the Epilepsy Neurogenetics Initiative (ENGIN) at Children’s Hospital of Philadelphia (CHOP)\, where she evalutes all children with neurodevelopmental disorders with or without epilepsy but she has a specific focus in children with pathogenic variants in the SLC6A1 gene and works closely with the SLC6A1 Connect group. \nWhen caring for children\, Dr. McDonnell is reminded of her sister and the comfort of knowing medical professionals were helping to manage her epilepsy. “I am always inspired by the doctors that helped our family\,” she says. “And as your doctor\, I care about your child and your family as if they were my own. I hope that is an experience that can be taken from every visit at CHOP.” \nJoin Cure GABA-A and Dr. Pamela Pojomovsky McDonnell on 2/15 at 8:45-9:45 PST for an educational and insightful session. \nIf you are unable to attend in person\, rest assured – the session will be recorded and made available on the Cure GABA-A YouTube channel for your convenience. \n \nJoin us in our shared mission to enhance the lives of patients with GABA-A Variants and contribute to a brighter future. URL:https://curegabaa.org/event/cure-gaba-a-recommended-physician-meet-and-greet-dr-pamela-pojomovsky/ ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/01/053e6d8d8e0f34e367bb3ad5400f5ef7-1.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240215T084500 DTEND;TZID=America/Los_Angeles:20240215T094500 DTSTAMP:20260420T020848 CREATED:20240127T054449Z LAST-MODIFIED:20240214T204442Z UID:2088-1707986700-1707990300@curegabaa.org SUMMARY:Cure GABA-A | Basic Genetic Concepts | Laina Lusk DESCRIPTION:Join us for an enlightening session with Dr. Laina Lusk\, a dedicated genetic counselor in the division of neurology at CHOP\n\n\nFamily Presentation with Laina Lusk \nCure GABA-A | Webinar | Insights from a Genetic Counselor: Childhood Epilepsy and Neurodevelopmental Disorders \nJoin us for an enlightening session with Laina Lusk\, a dedicated genetic counselor in the division of neurology at the Children’s Hospital of Philadelphia (CHOP). \nLaina Lusk’s research interest lies in unraveling the genetic mechanisms and clinical phenotypes associated with childhood epilepsy and related neurodevelopmental disorders. Armed with a BS in neuroscience from Bucknell University and an MMSc in human genetics and genetic counseling from Emory University\, she brings a wealth of knowledge to her role. \nWith prior clinical experience as a cancer genetic counselor and a background in neurodevelopmental disorders research\, Laina plays a crucial role in the Helbig Lab. As a clinical liaison\, she actively contributes to phenotyping projects\, furthering our understanding of these complex conditions. \nJoin Cure GABA-A and Laina on 2/15 at 8:45am PST for an insightful exploration of childhood epilepsy and neurodevelopmental disorders from a genetic counselor’s perspective. For more details\, contact us on our socials or email: info@curegabaa.org \nIf you are unable to attend in person\, rest assured – the session will be recorded and made available on the Cure GABA-A YouTube channel for your convenience. \n \nJoin us in our shared mission to enhance the lives of patients with GABA-A Variants and contribute to a brighter future. URL:https://curegabaa.org/event/cure-gaba-a-basic-genetic-concepts-dr-laina-lusk/ ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/01/912a8599b961d2012f0536301847b65a-1.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240220T110000 DTEND;TZID=America/Los_Angeles:20240220T120000 DTSTAMP:20260420T020848 CREATED:20240127T054455Z LAST-MODIFIED:20240220T033004Z UID:2092-1708426800-1708430400@curegabaa.org SUMMARY:Cure GABA-A | Phenotypic Manifestations Observed in Individuals with GABAAR DESCRIPTION:Gain insights and understanding into the impact of these variants on distinct traits.\n\n\nCure GABA-A | Educational Session with Q&A | Phenotypic manifestations observed in individuals with GABAAR Variants \nJoin us for an educational session with Dr. Sebastian Ortiz. \nDr. Sebastian Ortiz is presently engaged in a comprehensive examination of the phenotypic manifestations observed in individuals possessing GABAAR variants. His aim is to enhance comprehension of the intricate networks and systems implicated in the pathophysiology of these disorders. Additionally\, he endeavors to equip clinicians with tools facilitating the early identification of these disorders. \nDr. Sebastian Ortiz is actively engaged in international epilepsy communities\, serving as the Chair of the Young Epilepsy Section from International League Against Epilepsy (ILAE) from September 2023 to September 2025. His contributions to various international congresses\, including the International Epilepsy Congress and Latin American Epilepsy Congress\, reflect his dedication to advancing knowledge in his field. \nA multilingual professional\, Sebastian is fluent in Portuguese\, Spanish\, English\, and has a basic proficiency in French and Danish. He is a member of prestigious associations such as the Danish Epilepsy Society\, International League Against Epilepsy (ILAE)\, American Academy of Clinical Neurophysiology. \n \nJoin Cure GABA-A and Dr. Sebastian Ortiz on February 20th\, 2024\, at 11:00 AM PST for an educational session. For more details\, contact us on our socials or email: monica@cureGABAa.com. \nCan’t make it in person? Don’t worry – This session will be recorded and uploaded to the Cure GABA-A YouTube channel for your convenience. \n \nJoin us in our collective mission to improve t URL:https://curegabaa.org/event/cure-gaba-a-phenotypic-manifestations-observed-in-individuals-with-gabaar/ ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/01/c90168e36844c5133d1ae92f965e573f-1.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240220T130000 DTEND;TZID=America/Los_Angeles:20240220T140000 DTSTAMP:20260420T020848 CREATED:20240217T030104Z LAST-MODIFIED:20240220T033004Z UID:2555-1708434000-1708437600@curegabaa.org SUMMARY:Cure GABA-A | Motor Cortex Measures of Cortical Inhibition DESCRIPTION:Motor Cortex Measures of Cortical Inhibition: What the motor system can tell us about the rest of the brain.\n\n\nCure GABA-A | Educational Session with Q&A | Phenotypic manifestations observed in individuals with GABAAR Variants \nJoin us for an educational session with Dr. Alexander Rotenberg. \nDr. Alexander Rotenberg is a prominent neurologist and epileptologist\, serving as the Director of the Neuromodulation Program within the Department of Neurology. He has received recognition for his work\, including the 2016 Dreifuss-Penry Epilepsy Award from the American Academy of Neurology and presidency of the Greater Boston Epilepsy Society in 2015-2016. \nDr. Rotenberg leads efforts to adapt noninvasive brain stimulation techniques like TMS and DCS for pediatric epilepsy patients\, while also overseeing basic science experiments exploring their translational applications in epilepsy and traumatic brain injury models. His ongoing research includes clinical trials testing the efficacy of brain stimulation in drug-resistant seizures\, studies on human brain plasticity in autism. \nJoin Cure GABA-A and Dr. Alexander Rotenberg on February 20th\, 2024\, at 1:00 PM PST for an educational session. For more details\, contact us on our socials or email: monica@cureGABAa.com. \nCan’t make it in person? Don’t worry – This session will be recorded and uploaded to the Cure GABA-A YouTube channel for your convenience. \n \nJoin Cure GABA-A in this collective mission to improve the lives of patients with GABA-A Variants work toward a brighter future. URL:https://curegabaa.org/event/cure-gaba-a-motor-cortex-measures-of-cortical-inhibition/ ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/02/1c0f171241b4551fd532a6ecab5e9280-1.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240227T120000 DTEND;TZID=America/Los_Angeles:20240227T130000 DTSTAMP:20260420T020848 CREATED:20240127T054440Z LAST-MODIFIED:20240226T211341Z UID:2080-1709035200-1709038800@curegabaa.org SUMMARY:Cure GABA-A | GoF: Discussion on Compounds; Which Ones Work\, Don't & Why? DESCRIPTION:Dr. Michael Rogawski\, from UC Davis Health\, will explain the Clinical presentation of GABR Variants and current treatments\n\n\nJoin us for an educational session with Dr. Michael Rogawski. \nDr. Michael Rogawski\, a professor and physician at UC Davis Health\, will explain the Clinical presentation of GABR Variants and current treatments. \nHe has been elected a fellow of the National Academy of Inventors (NAI)\, the highest professional distinction for academic inventors. His inventions in drug discovery and development\, particularly in the field of neuropharmacology\, have led to significant advancements in treating epilepsy and neuropsychiatric conditions. \nDr. Rogawski’s election as an NAI fellow recognizes his prolific spirit of innovation and contributions to improving the quality of life through groundbreaking inventions. Notable achievements include the development of epilepsy drug perampanel (Fycompa®) and brexanolone (Zulresso™)\, the first FDA-approved drug for postpartum depression. His work reflects a dedication to translational research and collaboration within the scientific community. \nJoin Cure GABA-A and Dr. Michael Rogawski on Feb 27\, 2024 12:00 PM PST for an educational session. For more details\, contact us on our socials or email: monica@cureGABAa.com. \nCan’t make it in person? Don’t worry – This session will be recorded and uploaded to the Cure GABA-A YouTube channel for your convenience. \n \nJoin us in our collective mission to improve the lives of patients with GABA-A Variants and work toward a brighter future. URL:https://curegabaa.org/event/cure-gaba-a-webinar-clinical-presentation-of-gabr-variants-and-current/ ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/01/909be920dac8b8fc6a520c5baeb4ceee-1.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240312T110000 DTEND;TZID=America/Los_Angeles:20240312T120000 DTSTAMP:20260420T020848 CREATED:20240127T054411Z LAST-MODIFIED:20240311T195920Z UID:2059-1710241200-1710244800@curegabaa.org SUMMARY:Cure GABA-A | Understanding the benefits of a Natural History Study DESCRIPTION:Join us for an engaging online session where we’ll explore the advantages of a Natural Historical Study\n\n\nCure GABA-A | Educational Session with Q&A | Understanding the benefits to patients of a Natural History Study \nEvent Description: Join us for an informative online session on GABA-A\, where we will delve into the benefits a Natural History Study offers to patients. Our expert Dr. Rikke Steensbjerre Møller will provide insights on the natural history of GABA-A and how it can be a game-changer in patient care. \nGet ready to have your questions answered during the interactive Q&A session. \nDr. Rikke Steensbjerre Moller leads the dedicated team at the Danish Epilepsy Centre\, the primary focus is enhancing the diagnosis process for individuals with severe genetic epilepsy through advanced genetic testing. \nCommitted to fostering awareness about genetic epilepsies\, they recognize the profound impact of natural history in genetic epilepsies. \nDr. Moller and her team strive to deepen their understanding of the correlations between genetic factors and clinical symptoms\, all while actively seeking out innovative treatment options. \n \nCure GABA-A has invited all of our friends to join an educational session with Dr. Rikke Steensbjerre Møller January 29th\, 2023 10am PDT. For more details contact us on our socials or email: monica@cureGABAa.com\n \nCan’t make it in person? Don’t worry –This session will be recorded and uploaded to the Cure GABA-A YouTube channel for your convenience. \n \nwww.youtube.com/@CureGABAa \n \nJoin Cure GABA-A in this collective mission to improve the lives of patients with GABA-A Variants work toward a brighter future. URL:https://curegabaa.org/event/cure-gaba-a-understanding-the-benefits-of-a-natural-history-study/ ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/01/ccd8217ce4c48a656e83e476b8e181a6.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240322T100000 DTEND;TZID=America/Los_Angeles:20240322T110000 DTSTAMP:20260420T020848 CREATED:20240321T025902Z LAST-MODIFIED:20240322T025934Z UID:2815-1711101600-1711105200@curegabaa.org SUMMARY:Cure GABA-A | Understanding GABA-A and its Relationship to Epilepsy DESCRIPTION:Dr. Michael Rogawski\, from UC Davis Health\, will help us understand GABA-A and its relationship to epilepsy\n\n\nJoin us for an educational session with Dr. Michael Rogawski. \nDr. Michael Rogawski\, a professor and physician at UC Davis Health\, will help us understand GABA-A and its relationship to Epilepsy. \nDr. Rogawski has been elected a fellow of the National Academy of Inventors (NAI)\, the highest professional distinction for academic inventors. His inventions in drug discovery and development\, particularly in the field of neuropharmacology\, have led to significant advancements in treating epilepsy and neuropsychiatric conditions. \nDr. Rogawski’s election as an NAI fellow recognizes his prolific spirit of innovation and contributions to improving the quality of life through groundbreaking inventions. Notable achievements include the development of epilepsy drug perampanel (Fycompa®) and brexanolone (Zulresso™)\, the first FDA-approved drug for postpartum depression. His work reflects a dedication to translational research and collaboration within the scientific community. \nJoin Cure GABA-A and Dr. Michael Rogawski on March 22\, 2024 10:00 AM PDT for an educational session. For more details\, contact us on our socials or email: monica@cureGABAa.com. \nCan’t make it in person? Don’t worry – This session will be recorded and uploaded to the Cure GABA-A YouTube channel for your convenience. \n \nJoin us in our collective mission to improve the lives of patients with GABA-A Variants and work toward a brighter future. URL:https://curegabaa.org/event/cure-gaba-a-understanding-gaba-a-and-its-relationship-to-epilepsy/ ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/03/9ea401c2d4d67dc4f2f23103cd8b4a5d-1.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20240404T090000 DTEND;TZID=America/New_York:20240405T170000 DTSTAMP:20260420T020848 CREATED:20240228T182035Z LAST-MODIFIED:20240405T173628Z UID:2633-1712221200-1712336400@curegabaa.org SUMMARY:On Site Bio Collection | CombinedBrain DESCRIPTION:CombinedBrain will do an onsite bio sample collection\n\n\nCombinedBrain will be collecting BioSamples from patients with genetic mutations. \nThis is an opportunity for our Cure GABA-A community to donate their bio samples. \nLearn More \nWhat does this mean? Why is this important? \nPlease watch this video below: URL:https://curegabaa.org/event/on-site-bio-collection-combinedbrain/ LOCATION:Embassy Suites by Hilton Orlando Lake Buena Vista Resort\, 8100 Lake Street\, Orlando\, FL\, 32836\, United States ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/02/3c864a3aced69b5753ceb0d6374bd62e.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240422T110000 DTEND;TZID=America/Los_Angeles:20240422T120000 DTSTAMP:20260420T020848 CREATED:20240127T054501Z LAST-MODIFIED:20240422T173137Z UID:2096-1713783600-1713787200@curegabaa.org SUMMARY:Cure GABA-A | Recommended Physician Meet and Greet | Dr. Juliet Knowles DESCRIPTION:Dr. Juliet Knowles is a Cure GABA-A recommended physician at Standford Medicine\n\n\nCure GABA-A | Recommended Physician Meet and Greet | Dr. Juliet Knowles \nJoin us for an educational session with Dr. Juliet Knowles\, MD\, PhD\, Cure GABA-A’s Recommended Physicians at Stanford University. \nDr. Juliet Knowles will provide valuable insights into the clinical presentation of GABR Variants and the latest advancements in current treatments. As a distinguished researcher\, Dr. Knowles leads a dynamic lab at Stanford focusing on the mechanisms underlying pediatric epilepsy. Her research group is particularly interested in understanding generalized epilepsies\, monogenic epilepsies\, and developmental and epileptic encephalopathies. Notably\, her lab recently uncovered an unexpected contribution of activity-dependent myelination to the progression of generalized epilepsy (J.K. Knowles et al\, Nature Neuroscience\, 2022). \nCurrently\, the Knowles lab is investigating whether similar mechanisms are at play in various forms of genetic epilepsy\, including GABA-A related epilepsy. Dr. Knowles\, in addition to her research role\, is a dedicated clinician providing specialty care for children with genetic and challenging-to-treat forms of epilepsy\, making her a highly recommended physician in this field. \nJoin Cure GABA-A and Dr. Juliet Knowles on 4/22/2024 at 11am PST for an educational and insightful session. \nIf you are unable to attend in person\, rest assured – the session will be recorded and made available on the Cure GABA-A YouTube channel for your convenience. \n \nJoin us in our shared mission to enhance the lives of patients with GABA-A Variants and contribute to a brighter future. URL:https://curegabaa.org/event/cure-gaba-a-recommended-physician-meet-and-greet-dr-juliet-knowles/ ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/01/a99e88015b958556f016733734f6de3e-1.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240423T110000 DTEND;TZID=America/Los_Angeles:20240423T120000 DTSTAMP:20260420T020848 CREATED:20240404T101548Z LAST-MODIFIED:20240422T173137Z UID:2906-1713870000-1713873600@curegabaa.org SUMMARY:Cure GABA-A | The Role of GABA During Development DESCRIPTION:His research delves into rare genetic epilepsies associated with specific gene mutations\, utilizing advanced techniques such as brain slice\n\n\nFamily Presentation with Dr. Kirill Zavalin\n \nCure GABA-A | The Role of GABA During Development \n \nJoin us for an informative meet and greet session with Dr. Kirill Zavalin\, a dedicated postdoctoral fellow at Vanderbilt University Medical Center. Dr. Zavalin specializes in genetic epilepsy and brain development\, with a particular focus on GABAergic neurotransmission. His research delves into rare genetic epilepsies associated with specific gene mutations\, utilizing advanced techniques such as brain slice electrophysiology and molecular biology. \n \nDr. Zavalin’s expertise and passion lie in unraveling the complexities of epilepsy\, aiming to contribute to the advancement of biomedical neuroscience research. With a wealth of experience in academic writing\, presentations\, teaching\, and collaboration\, Dr. Zavalin is well-equipped to make significant strides in epilepsy studies and improve patient outcomes. \n \nJoin Cure GABA-A and Dr. Kirill Zavalin on April 15th\, 2024 11:00am PT for an engaging and insightful session. For more details\, contact us on our socials or email: info@curegabaa.org \n \nIf you are unable to attend in person\, rest assured – the session will be recorded and made available on the Cure GABA-A YouTube channel for your convenience. \n \n \n \nJoin us in our shared mission to enhance the lives of patients with GABA-A Variants and contribute to a brighter future. URL:https://curegabaa.org/event/cure-gaba-a-the-role-of-gaba-during-development/ ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/04/b00e994bbb3041948149a2b9bee98427.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240528T110000 DTEND;TZID=America/Los_Angeles:20240528T120000 DTSTAMP:20260420T020848 CREATED:20240526T073155Z LAST-MODIFIED:20240528T072840Z UID:2994-1716894000-1716897600@curegabaa.org SUMMARY:Cure GABA-A | What do we need to know about Gain of Function GABAAR DESCRIPTION:What do we need to know about Gain of Function GABAA receptor variants?\n\n\nUnderstanding Gain of Function GABAA Receptor Variants\nGABAA Receptor Variants | Research Insights Session | Dr. Lidong Liu \nJoin us for an enlightening session with Dr. Lidong Liu\, Senior Research Scientist at the University of British Columbia’s Department of Neurology and the DM Centre for Brain Health. \nDr. Liu\, in collaboration with Dr. Yu Tian Wang\, focuses on the molecular mechanisms of synaptic function and plasticity\, particularly under conditions of health and disease. This session will describe GABAA receptor variants and their implications for epilepsy. \nThese groundbreaking insights are crucial for developing better treatments for conditions like epilepsy. Dr. Liu’s work highlights the dynamic interplay between neurotransmitter systems and offers new avenues for therapeutic intervention. \nEvent Details: \n\nDate: 5/28/2024\nTime: 11am PDT\n\nIf you cannot attend in person\, don’t worry—the session will be recorded and available on our YouTube channel. \nJoin us to learn from Dr. Liu’s expertise and contribute to our shared mission of improving the lives of patients with GABAA receptor variants. \nProject Overview: \n\nGABAA Receptor Study: This project focuses on understanding GABAA receptors.\nInitial Discovery: The first GABRA1 variant (A322D) was identified in epilepsy patients about 20 years ago.\nRecent Work: Recently\, more variants have been characterized\, and some repurposed drugs have been tested on these variants based on requests from doctors and patients’ families.\n\nKey Discoveries: \n\nGlutamate and GABAA Receptor Crosstalk:\nSignificance: There is an important interaction between glutamate and GABAA receptors.\nMechanism: Glutamate can bind to and enhance GABAA receptors to balance out the overexcitation caused by glutamate receptors.\nResearch Model: Mice with mutations in the glutamate binding site of GABAA receptors showed increased neuronal excitability\, seizure susceptibility\, and autism-like behaviors.\nNetrin-1’s Role:\nFunction: Netrin-1\, a molecule that guides axons\, is secreted during high neuronal activity.\nEffect: It binds to GABAA receptors and increases their function\, helping to balance synaptic activity by enhancing the conductance of these channels. URL:https://curegabaa.org/event/cure-gaba-a-what-do-we-need-to-know-about-gain-of-function-gabaar/ ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/05/f1d24b9620acb6390d5f7155e6ff2514-1.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240529T100000 DTEND;TZID=America/Los_Angeles:20240529T110000 DTSTAMP:20260420T020848 CREATED:20240526T073209Z LAST-MODIFIED:20240528T072840Z UID:2998-1716976800-1716980400@curegabaa.org SUMMARY:Cure GABA-A | Dr. Ortiz Community Update Meeting DESCRIPTION:We invite you to a special presentation that will NOT be recorded. Dr. Ortiz will discuss three key points for our community.\n\n\nWe invite you to a special presentation that will NOT be recorded. Dr. Ortiz will discuss three key points at our upcoming Cure GABA-A meeting for patients and caregivers: \n \n1. The preliminary results of the antiseizure medication survey completed by our community. \n(https://filadelfia-science.dk/surveys/?s=TEX9JXNK3CPWTNA4) \n \n2. An explanation of the Sleep Disturbance Scale for our children. \n \n3. The GABAAR Movement Disorders clinical video proposal featuring the MyDystonia electronic diary. \n \nWe hope to see you all there. URL:https://curegabaa.org/event/cure-gaba-a-dr-ortiz-community-update-meeting/ ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/05/e678b4aa2c9d7883d74f72279b0f50a1-1.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240627T130000 DTEND;TZID=America/Los_Angeles:20240627T140000 DTSTAMP:20260420T020848 CREATED:20240626T183301Z LAST-MODIFIED:20240627T184424Z UID:3092-1719493200-1719496800@curegabaa.org SUMMARY:Cure GABA-A | Artificial Intelligence (AI)-driven Drug Repurposing for Rare DESCRIPTION:Aleksandra Foksinska\, Program Manager\, and Alexandria Howard\, Case Analyst at UAB Hugh Kaul Precision Medicine Institute\, research AI-driven\n\n\nAleksandra Foksinska and Alexandria Howard will both discuss Artificial Intelligence (AI)-driven Drug Repurposing for Rare Disease. \nAleksandra Foksinska is the Program Manager at the UAB Hugh Kaul Precision Medicine Institute. Her background is in Molecular Biology (BS) and Biomedical Sciences (MS) from the University of Alabama at Birmingham. Aleksandra’s research interests include identifying drug repurposing candidates for rare genetic disorders using AI. Aleksandra also serves as a project coordinator for the UAB Center for Precision Animal Modeling\, as well as a committee member for the Undiagnosed Diseases Network Therapeutic Matching Committee. \nAlexandria Howard is a Case Analyst at the UAB Hugh Kaul Precision Medicine Institute. She is currently approaching her senior year at the University of Alabama at Birmingham with a double major in Genetics/Genomic Sciences and Neuroscience and a minor in Chemistry. Alexandria’s research interests include investigating various rare genetic disorders and identifying drug repurposing candidates using AI. URL:https://curegabaa.org/event/cure-gaba-a-artificial-intelligence-ai-driven-drug-repurposing-for-rare/ ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/06/71125d09bbf5aa52e477b4e421030c69-1.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20240628T100000 DTEND;TZID=America/Los_Angeles:20240628T110000 DTSTAMP:20260420T020848 CREATED:20240626T183309Z LAST-MODIFIED:20240627T184424Z UID:3096-1719568800-1719572400@curegabaa.org SUMMARY:Cure GABA-A | Genotype-phenotype correlation&precision treatment of epilesy DESCRIPTION:The research focuses on genetic epilepsy\, aiming to identify severe epilepsy genotypes and develop precision therapies.\n\n\nThe current landscape shows increasing insights into human genetics\, yet the translation of genetic data into actionable patient care concepts lags behind. This gap is influenced by two primary challenges: the variability in clinical outcomes associated with different genetic variants within a single gene\, complicating treatment decisions\, and the empirical nature of current epilepsy treatments due to the absence of targeted therapies for specific genetic changes. \nOur specific focus is on the genetic LOF variant D120N in the GABRB3 gene’s beta-3 subunit\, known for severe forms of developmental and epileptic encephalopathy (DEE)\, such as Lennox Gastaut Syndrome (LGS). This variant’s location in the gene’s extracellular region suggests a correlation with clinical severity based on functional domains. However\, understanding which genetic variants correlate with mild or severe presentations remains a challenge\, impacting prognostication and treatment strategies. Furthermore\, the pathophysiology and underlying cellular mechanisms associated with these genetic variants require further investigation. \nThrough this research\, I aim to contribute to the advancement of personalized medicine\, ultimately improving outcomes for children affected by genetic epilepsy. URL:https://curegabaa.org/event/cure-gaba-a-genotype-phenotype-correlationprecision-treatment-of-epilesy/ ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2024/06/0a00c3597b9dc28dc63fee28a583eac9-1.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20250926T130000 DTEND;TZID=America/Los_Angeles:20250926T143000 DTSTAMP:20260420T020848 CREATED:20250923T065822Z LAST-MODIFIED:20250926T071539Z UID:4354-1758891600-1758897000@curegabaa.org SUMMARY:CURE GABA-A | Grann Pharmaceuticals mRNA Protein Replacement for GABAARs DESCRIPTION:First glimpse at mRNA protein replacement for GABAAR disorders. Join CURE GABA-A + Grann Pharma live Q&A this Friday at 1PM PST.\n\n\nCURE GABA-A | Grann Pharmaceuticals: mRNA Protein Replacement for GABAAR Disorders \n \nDate & Time\n📅 Friday\, September 26th 2025🕐 1:00 PM PST | 4:00 PM EST \nLocation\nOnline Event (Zoom link provided upon registration) \nDescription\n🚨 STOP WHAT YOU’RE DOING 🚨 \nThis is the moment everything we’ve worked for comes down to. We started CURE GABA-A with one mission: to get pre clinical data for treatments relating to GABAAR disorders as quickly and safely as possible. And now\, we are finally at the beginning. \nGrann Pharmaceuticals has developed an mRNA-based protein replacement therapy for GABRA1 and GABRG2 variants. This therapy is already produced and ready for preclinical testing. With the right support\, we can bring it to the FDA and into clinical trials by the end of 2026. \nBut science alone isn’t enough. We need the community to band together now\, fundraising\, donating\, and spreading the word\, to make this therapy a reality for children and families. \nJoin us for a live Q&A with Tommy Temple\, CEO of Grann Pharmaceuticals\, as he explains: \n\nWhat mRNA protein replacement therapy is\nWhy it could be the first treatment for GABAAR disorders\nThe FDA pathway and clinical trial timeline\nHow YOU can make the difference to bring this to clinic\n\n💙 Together we can move from hope to treatment. \n \nAgenda\n\nWelcome from CURE GABA-A\nPresentation by Tommy Temple (CEO\, Grann Pharmaceuticals)\nLive Q&A session\nCall to Action: How to Fundraise and Donate\n\n \nTickets\n🎟️ Free – Registration required.Donations encouraged: https://www.facebook.com/donate/4300256346872932/ \nor GoFundMe: https://www.gofundme.com/f/lifesaving-gene-therapy-drug \n \nCall to Action\n✨ Every donation moves us closer to the first-ever GABAAR clinical trial.✨ Every fundraiser brings hope to families waiting for answers. \n👉 Register now\, join the movement\, and help us make history. URL:https://curegabaa.org/event/cure-gaba-a-grann-pharmaceuticals-mrna-protein-replacement-for-gabaars/ ATTACH;FMTTYPE=image/jpeg:https://curegabaa.org/wp-content/uploads/2025/09/eb129fe2f5040dd1250b287baff34beb.jpg ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20261203 DTEND;VALUE=DATE:20261205 DTSTAMP:20260420T020848 CREATED:20251210T173503Z LAST-MODIFIED:20260121T213743Z UID:4631-1796256000-1796428799@curegabaa.org SUMMARY:2026 CURE GABA-A Family & Scientific Conference DESCRIPTION:2026\nCURE GABA-A Family & Scientific \nConference\n \n \n \n \n \n December 3rd -4th 2026\, Denver Colorado USA \n \n Register to Attend\n \n Sponsor the Conference\n \n \n \n \n \n Two days of scientific presentations\, family programming\, GABA-A Receptor research updates\, and global collaboration. \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 2023 Roundtable\n \n \n \n \n \n \n \n 2024 Conference\n \n \n \n \n \n \n \n 2025 European Conference\n \n \n \n \n \n \n \n 2025 Conference\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Countdown\n \n \n Day(s) \n \n : \n \n \n Hour(s) \n \n : \n \n \n Minute(s) \n \n : \n \n \n Second(s) \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n   \nWhat\, When and Where\n\n\n\n\n\n\n\n\n\n\n\nWhat:\n2026 CURE GABA-A Family & Scientific Conference \n \nWhen:\n\n\n\n\nFamily Meeting | December 2nd\, 2026 \nScientific Meeting | December 3rd\, 2026 \nWhere:\nDenver\, Colorado – Hotel Details to be confirmed by Q2 of 2026 \n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Featured Talks & Speakers\n \n Full Schedule Available soon\n \n \n \n \n \n \n \n \n \n \n \n \nWhat to Expect\nDiscover the leading voices shaping the future of GABAAR research. \nOur 2026 conference features presentations from global experts in GABAAR science\, neuroscience\, clinical care\, gene therapy\, and translational research. \nAttendees will hear the latest updates on GABAAR science\, therapeutic development\, natural history studies\, iPSC research\, animal models\, and real-world clinical insights. \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Rikke S Møller\nProfessor\, Coordinative Head of Research\, IRS \nThe Epilepsy hospital Filadelfia \nNatural History and EEG Biomarkers \n \n More Details\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Jingqiong Kang (Katty)\nAssociate Professor of Neurology and Pharmacology \nVanderbilt University Medical Center \nRavicti Repurposing \n \n More Details\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Henry Lee\nPreclinical Scientific Program Manager \nHarvard Medical School \nGene Replacement Therapy \n \n More Details\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Thomas Lyle Temple\nCEO\, Grann Pharmaceuticals  \nmRNA Therapy \n \n  \n \n More Details\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n SCIENTIFIC PROGRAM\n \n \n \n \n \n \n \n FAMILY PROGRAM\n \n \n \n \n \n \n \n BIO SAMPLE COLLECTION\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n 2026 Conference Highlights\n\nUpdated GABAAR research\nmRNA protein replacement therapy progress\nGene Replacement Therapy progress\nMouse model and zebrafish updates\nOn-site bio sample collection through COMBINEDBrain\nParent and caregiver workshops\nGlobal scientific and advocacy speakers\nOpportunities to network with researchers\nDedicated respite room and support resources\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Venue\n Our venue will be announced soon. We are finalizing a location that provides: \n\nSpacious meeting rooms\nComfortable accommodations\nFamily-friendly dining options\nAccessibility features\nEasy access to Denver International Airport (DEN)\n\nFull venue details and the hotel room block will be added here as soon as they are confirmed. \nHotel Room Block\nWe will be offering a discounted room block for attendees.Room block details\, including booking links and deadline dates\, will be released once the venue contract is finalized. \nWe encourage you to check this page regularly or join our email list for updates. \nTravel Planning\nTo help families manage costs\, we encourage booking airfare as early as February. Flights to Denver tend to increase in price as summer approaches\, so early planning can make a big difference. \n \n \n \n \n \n On-Site Bio sample Collection\n \n\n\n\n\nAt the 2026 CURE GABA-A Conference\, families will have the opportunity to take part in on-site bio sample collection through COMBINEDBrain\, our national research and bio collection partner. \n \nWho Can Participate\nFamilies of individuals with confirmed or suspected GABAAR variants are welcome to take part. Samples may include saliva\, blood\, or other non-invasive collections depending on the research protocol.\n \nWhy It Matters\nEvery sample helps researchers better understand GABAAR variants and how they affect development\, seizures\, expression\, and brain function. These samples accelerate the development of new treatments\, including mRNA therapy\, protein replacement\, drug screening\, and biomarker discovery.\nYour contribution moves research forward in a tangible\, measurable way.\n \nWhat COMBINEDBrain Does\nCOMBINEDBrain is a leading research consortium focused on severe neurodevelopmental disorders. They work with top scientists and hospitals to process\, store\, and analyze biosamples so data can be used responsibly and effectively across multiple research programs. Their work ensures that every sample contributes to real progress.\n \nHow to Sign Up\nWe will release a sign-up link closer to the event. Families will be able to select a time slot that works best for their schedule.\nSpaces may be limited\, so we encourage early registration once sign-ups open.\n\n\n\n\n\n\n \n \n Bio Collection Registry\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n For Families\n Learn the latest science in a supportive environment \nConnect with families from around the world \nAccess resources and variant-specific insights \nParticipate in biosample programs that accelerate research \nMeet the scientists who are actively working on GABAAR therapeutics \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Researchers & Clinicians\n Present your work to a global\, engaged audience \nAccess a rare and concentrated dataset across GABA-A receptor variants \nEngage directly with families and community leaders \nCollaborate with global labs \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n For Sponsors\n Align with high-impact rare disease research \nGain visibility among families\, scientists\, and clinicians \nSupport the advancement of GABAAR  therapeutics \nReinforce your corporate commitment to neurological innovation \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Our Sponsors\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Thanking our previous years sponsors\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Register Now!\n \n \n \n \n \n Lorem ipsum dolor sit amet\, consectetur adipiscing elit. Quisque placerat sapien condimentum imperdiet cursus. Lorem ipsum dolor sit amet\, consectetur adipiscing elit. Quisque placerat sapien condimentum imperdiet cursus.\n \n Ticket Info\n \n \n \n \n \n \n \n \n \n \n \n \n Contact Us\n \n \n \n \n \n \n \n \n \n Name\n \n \n \n \n \n \n Email\n \n \n \n \n \n \n Message\n \n \n \n \n \n Submit\n \n \n \n \n \n \n \n \n \n \n Have questions? We’re here to help.Email: info@curegabaa.org  \n30765 Pacific Coast Hwy Suite 366 Malibu\, CA 90265 United States \nEIN: 93-1989277 URL:https://curegabaa.org/event/2026conference/ CATEGORIES:CURE GABA-A Conferences ORGANIZER;CN="CURE GABA-A":MAILTO:info@curegabaa.org END:VEVENT END:VCALENDAR